• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向人癌细胞上c-erbB-2产物的抗体-阿霉素偶联物对免疫选择性细胞生长的抑制作用

Immunoselective cell growth inhibition by antibody-adriamycin conjugates targeting c-erbB-2 product on human cancer cells.

作者信息

Suzuki S, Tanaka M, Masuko T, Hashimoto Y

机构信息

Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

出版信息

Biol Pharm Bull. 1995 Sep;18(9):1279-82. doi: 10.1248/bpb.18.1279.

DOI:10.1248/bpb.18.1279
PMID:8845823
Abstract

Monoclonal antibodies targeting c-erbB-2 protooncogene product p185 were conjugated with adriamycin via a pH-sensitive spacer. The resultant antibody-adriamycin conjugates showed immunoselective binding, internalization and cytotoxicity to p185-positive human breast cancer cell SKBr-3 and gastric cancer cell MKN-7, but not to normal human lymphocytes.

摘要

靶向c-erbB-2原癌基因产物p185的单克隆抗体通过一个pH敏感间隔物与阿霉素偶联。所得的抗体-阿霉素偶联物对p185阳性的人乳腺癌细胞SKBr-3和胃癌细胞MKN-7表现出免疫选择性结合、内化及细胞毒性,但对正常人淋巴细胞无此作用。

相似文献

1
Immunoselective cell growth inhibition by antibody-adriamycin conjugates targeting c-erbB-2 product on human cancer cells.靶向人癌细胞上c-erbB-2产物的抗体-阿霉素偶联物对免疫选择性细胞生长的抑制作用
Biol Pharm Bull. 1995 Sep;18(9):1279-82. doi: 10.1248/bpb.18.1279.
2
Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells.含阿霉素的抗c-erbB-2免疫脂质体对人癌细胞的细胞毒性
Br J Cancer. 1995 Sep;72(3):663-8. doi: 10.1038/bjc.1995.391.
3
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin.抗p185抗体抑制生长需要C-erbB-2基因产物(p185)的酪氨酸激酶活性,但抗p185-蓖麻毒素A链免疫毒素的细胞毒性则不需要该活性。
Int J Cancer. 1994 Oct 15;59(2):242-7. doi: 10.1002/ijc.2910590217.
4
Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells.p185(c-erbB-2)的细胞表面密度决定了卵巢癌细胞对单独使用抗p185(c-erbB-2)-蓖麻毒素A链(RTA)免疫毒素疗法以及与抗p170(EGFR)-RTA联合使用的敏感性。
Clin Cancer Res. 1998 Oct;4(10):2545-50.
5
Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines.
Surg Today. 1996;26(7):501-7. doi: 10.1007/BF00311556.
6
Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.抗p185HER-2蓖麻毒素A链免疫毒素与放射性核素缀合物之间的协同相互作用,用于抑制过表达HER-2的卵巢癌细胞和乳腺癌细胞的生长。
Clin Cancer Res. 2000 Aug;6(8):3334-41.
7
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.隐形脂质体靶向erbB-2(Her/2)受体的体外和体内研究。
Br J Cancer. 1996 Dec;74(11):1749-56. doi: 10.1038/bjc.1996.625.
8
Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.抗c-erbB-2抗体诱导的类配体效应与人类癌细胞的生长抑制不相关,且生长抑制并不需要该效应。
Cancer Res. 1994 Mar 1;54(5):1367-73.
9
Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.曲妥珠单抗和化疗药物对胃癌细胞系的生长抑制作用。
Cancer Lett. 2004 Oct 28;214(2):215-24. doi: 10.1016/j.canlet.2004.04.029.
10
Doxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug.多柔比星偶联抗中期因子单克隆抗体作为一种潜在的抗肿瘤药物。
Jpn J Clin Oncol. 2006 Apr;36(4):207-11. doi: 10.1093/jjco/hyl004. Epub 2006 Apr 12.